Home/Supreme Court/United States ex rel. Nathan v. Takeda Pharm. N. Am., Inc.

United States ex rel. Nathan v. Takeda Pharm. N. Am., Inc.

134 S. Ct. 374, 187 L. Ed. 2d 15, 571 U.S. 809, 82 U.S.L.W. 3178, 2013 WL 5507350, 2013 U.S. LEXIS 5280
Procedural entryThis page is a short order in United States ex rel. Nathan v. Takeda Pharm. N. Am., Inc.. Read the opinion of the Court — 134 S. Ct. 1759 →
Supreme Court of the United States·Decided October 7, 2013·No. No. 12–1349.·Published

Opinion

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

Free access — add to your briefcase to read the full text and ask questions with AI

United States ex rel. Nathan v. Takeda Pharm. N. Am., Inc., 134 S. Ct. 374, 187 L. Ed. 2d 15, 571 U.S. 809, 82 U.S.L.W. 3178, 2013 WL 5507350, 2013 U.S. LEXIS 5280 (U.S. 2013).

134 S. Ct. 374 (United States ex rel. Nathan v. Takeda Pharm. N. Am., Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.